WuXi AppTec (HKG:2359, SHA:603259) disposed of a further 50.8 million shares, equivalent to a 4.23% stake, in WuXi XDC Cayman (HKG:2268) for around HK$2.18 billion on Tuesday, a Wednesday filing with the Hong Kong bourse said.
The drug research and development company previously sold 86 million shares in the target company for roughly HK$2.43 billion on Nov. 8, 2024, and Jan. 10, 2025.
The firm will use proceeds from the sale to accelerate the construction of global production capacity and capability, attract and retain outstanding talent, and strengthen its unique integrated CRDMO business model.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。